Fostamatinib Impurity 5 | CAS 20348-21-4 - Request Quote
Fostamatinib Impurity 5
| SZ CAT No: | SZ-F046013 |
| CAS No | 20348-21-4 |
| Mol.F. | C9H10N2O2 |
| Mol.Wt. | 178.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Fostamatinib Impurity 5 is chemically 2,2-Dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one. Fostamatinib Impurity 5 is supplied with detailed characterization data compliant with regulatory guideline. Fostamatinib Impurity 5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fostamatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 20348-21-4
Purchase 20348-21-4
Order 20348-21-4
Enquire 20348-21-4
price of 20348-21-4
20348-21-4 Supplier
20348-21-4 Manufacturer
20348-21-4 Exporter
buy high quality Fostamatinib Impurity 5
Purchase Fostamatinib Impurity 5
Fostamatinib Impurity 5 suppliers
Fostamatinib Impurity 5 manufacturers
Fostamatinib Impurity 5 price
Order Fostamatinib Impurity 5
Enquire Fostamatinib Impurity 5
Fostamatinib Impurity 5 cost
Fostamatinib Impurity 5 Supplier
Fostamatinib Impurity 5 Distributor
Fostamatinib Impurity 5 for Method Validation
Fostamatinib Reference Standard
Fostamatinib Impurity 5 for ANDA Filing
Fostamatinib Impurity 5 for Forced Degradation Studies
Fostamatinib Impurity 5 Identification Standards
Fostamatinib Impurity 5 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.